Wall Gemma, Gustafsson Louise, Pearce Claire, Isbel Stephen
University of Canberra, Australian Capital Territory, Australia.
University of Canberra Hospital, Australian Capital Territory, Australia.
OTJR (Thorofare N J). 2024 Dec 11:15394492241300606. doi: 10.1177/15394492241300606.
Occupation-based groups can be used to improve occupational performance outcomes in the inpatient rehabilitation setting. It remains unclear whether they offer comparable outcomes to occupation-based interventions delivered individually. This study aims to pilot an occupation-based group intervention and compare occupational performance, satisfaction, and goal attainment outcomes with usual care. Twenty-one participants (15 women, 6 men, aged 34-85) were allocated to control ( = 11) and intervention ( = 10) groups. The control group received usual care (individual occupation-based interventions), while the intervention group received usual care plus an occupation-based group intervention. The method used a pilot quasi-experimental pre- to post-intervention design with a nonequivalent control group. The primary outcome measures were the Canadian Occupational Performance Measure (COPM) and the Goal Attainment Scale (GAS). No significant between-group differences were found; both groups reported statistically significant improvements with medium to large effect sizes. Pilot data suggests that occupation-based groups offered comparable outcomes to individual treatment; a larger sample size is required to draw conclusions on their impact. Australian New Zealand Clinical Trials Registry (https://uat.anzctr.org.au/Default.aspx) was accessed on November 20, 2023. Registration number: ACTRN12623001196639.
基于职业的小组干预可用于改善住院康复环境中的职业表现结果。目前尚不清楚它们与单独实施的基于职业的干预措施相比是否能产生可比的结果。本研究旨在试行一项基于职业的小组干预，并将职业表现、满意度和目标达成结果与常规护理进行比较。21名参与者（15名女性，6名男性，年龄34 - 85岁）被分配到对照组（n = 11）和干预组（n = 10）。对照组接受常规护理（基于个体职业的干预），而干预组接受常规护理加基于职业的小组干预。该方法采用了带有非等效对照组的干预前至干预后的试点准实验设计。主要结局指标为加拿大职业表现测量量表（COPM）和目标达成量表（GAS）。未发现组间有显著差异；两组均报告有统计学上显著的改善，效应量为中等到大。试点数据表明，基于职业的小组干预与个体治疗产生的结果相当；需要更大的样本量才能得出关于其影响的结论。于2023年11月20日访问澳大利亚新西兰临床试验注册中心（https://uat.anzctr.org.au/Default.aspx）。注册号：ACTRN12623001196639。
